We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Medicinal Compound Shown to Have Anticancer Effects on Hepatocellular Carcinoma

By Biotechdaily staff writers
Posted on 13 Nov 2007
A new report details the significance of a Chinese medicinal compound, delisheng, for the therapy of hepatocellular carcinoma (HCC).

Traditional Chinese medicine is renowned throughout the world, but its effect on certain diseases is poorly understood. More...
In an article that appeared in the November 7, 2007, issue of the World Journal of Gastroenterology, a team led by Dr. Ke-Jun Nan from the First Affiliated Hospital of the School of Medicine of Xi'an Jiaotong University (Xi'an, Shaanxi, China) reported on their studies of the compound.

HCC is a primary malignancy of the liver with a very high morbidity and mortality. In spite extensive efforts by many investigators, systemic chemotherapy for HCC has been quite ineffective. Delisheng is a medicinal compound that is frequently used in conjunction with chemotherapy for HCC, with satisfactory results. In this study, the researchers tried to establish the mechanisms for the effects of delisheng on HCC.

Three-dimensional (3D) cell cultures have been widely used for evaluating the various molecular mechanisms because spheroids mimic solid tumors more closely than monolayers. Therefore, the use of 3D cultures provides a model for the development of anti-cancer drugs. In the study, cells were cultured with a liquid-overlay technique. After the formation of multicellular spheroids, the investigators used the model to perform their experiments.

One conclusion reported by the investigators is that 3D cell cultures are suitable for the study of traditional Chinese medicinal compounds, and this may help other researchers find a better model for drug development. Another interesting conclusion is that delisheng has satisfactory anti-cancer effects on HCC, which were associated with the upregulation of endostatin. This is made possible by one of delisheng's components, ginseng, and may point to a new therapy for HCC.

This is the first reported finding of a model that can be used for studying traditional Chinese medicine. Furthermore, the view that the satisfactory effects of delisheng were associated with the upregulation of endostatin made possible by ginseng might motivate other researchers to examine the compound.


Related Links:
Xi'an Jiaotong University

New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Steam Sterilizer
Hi Vac II Line
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.